Lateral flow biosensors (LFBs) provide advantages in low cost, simplicity, rapidity, stability and portability, thus making LFBs popular in biomedical, agriculture, food and environmental sciences. This article reviews recent advances of LFBs for bioassays, including the investigation of the improvements achieved by signal-amplification strategies, the application of new nanoparticle labels, novel quantitative system and simultaneous detection. We summarized the outstanding performances of LFBs such as high detection sensitivity, specificity, reproducibility and reliability.
Introduction
In the last decades, the detecting of biothreat agents, chemical contaminants and biomolecules has attracted much attention and various new methods including real-time polymerase chain reaction (RT-PCR) [1] [2] [3] [4] , DNA microarrays [5] [6] [7] [8] , enzyme linked immunosorbent assay (ELISA) [9] [10] [11] [12] [13] , HPLC-MS [14-17] and immunosensor techniques [18] [19] [20] [21] [22] [23] have been employed. These methods offer high accuracy, but often require time-consuming sample pretreatment, technical expertise, sophisticated and expensive instrumentation, which are inappropriate for point-of-care testing and home testing. Lateral flow biosensors (LFBs), as a promising tool for detecting analyte, have recently attracted considerable interest because of their speed, simplicity, sensitivity, specificity, easy handling, and can potentially provide "instantaneous" diagnosis near the patients [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . Originally the LFBs was used in human chorionic gonadotrophin (HCG) immunoassay and called "sol particle immunoassay" (SPIA) [34, 35] . Since then, the LFB was widely applied in environmental monitoring, food safety, and clinical diagnosis for visual (qualitative) [57, 58] . The principle of LFBs is based on a solid-phase chromatographic test strip containing dry reagents those are activated by applying the fluid sample. Antibodies are immobilized on different positions of the LFB to capture target antigens and the colored detector reagents labeled on antibodies give the colored responses on the test zone and control zone on the LFB. The characteristic colored bands enable visual detection of target analyte without instrumentation. For quantitative measurements, the optical intensities of the test zone and control zone could be recorded simultaneously by corresponding instrumentation [59, 60] .
The aim of this article is to review major advances in recent years in LFB development and to compare the currently evaluated LFB with the traditional LFB. New strategies from these studies were presented and discussed including:
1. investigation of the improvements achieved by signal-amplification strategies; 2. application of new nanoparticle labels; 3. introducing of novel quantitative system; 4. simultaneous detection of multiple analytes.
LFB assay formats and principle
The LFB are designed to test the absence or presence of target analyte. The analyte might be the pathogens, hormones, drugs or metabolites. A specific labeled-antigen or labeled-antibody to the analyte is used for recognition. The LFB consists of four sections: sample application pad, conjugate pad, membrane and absorption pad. All of the components are laminated on a common sheet of plastic adhesive backing orderly using the clamshell laminator. Each pad overlaps 2 mm to allow the migration of sample solution along the LFB during the analysis.
Various possible formats have been described for LFBs, which are depending on the types of target analytes. The competitive assay and sandwich assay are the two most frequently used formats. When the target analyte is with low molecular weight or presenting single specific antigen, it is suitable for employing competitive format [61, 62, 48] . There are two approached based on the competitive format: 1) the specific antibody is firstly dispensed on the test zone. After applying the sample solution (containing the target antigen and the labeled antigen) to the sample application pad, the target antigen and labeled antigen would compete for binding on the specific antibody, which is immobilized on the test zone; 2) the sample solution containing target antigen is firstly incubated with the specific antibody to form the antigen-antibody complex. The antigen-antibody complex and labeled antibody would compete for binding on the specific antigen-protein conjugate, which is immobilized on the test zone [63] .
As shown in Figure 1 , in a typical competitive format, a monoclonal antibody (specific to target analyte-progesterone) immobilized on the test zone of a nitrocellulose (NC) membrane captures a colored reagent labeled analyte conjugate (progesteroneovalbumin/GNPs conjugate), enabling colored reagent (colloidal gold nanoparticles (GNPs)) to accumulate on the test zone and form a characteristic red line on the test zone. The control line was immobilized by another specific protein to capture the excess colored reagent labeled conjugate. In the present (or higher than the cutoff value) of the target analyte, the target analyte (progesterone) and colored reagent labeled analyte (progesterone-ovalbumin/GNPs conjugate) would compete for binding on the test zone. Owing to the binding affinity and steric effect, the target analyte would bind on the test zone prior to colored reagent labeled analyte. In this case, only one characteristic red band can be observed from the control zone. Conversely, in the absence (or lower than the cutoff value) of target analyte, numerous colored reagent-labeled analyte would bind on test zone, and two characteristic red lines can be observed from the test zone and control zone respectively. On the other hand, when the target analyte owns more than one specific antibodies or DNA aptamers, sandwich format could be employed to test the target analyte [64] [65] [66] [67] [68] [69] [70] 33, 71] . Figure 2 presents the typical DNA aptamers-based sandwich format. A pair of specific DNA aptamers (two aptamer probes, which could bind target thrombin in two different sites) was employed to test target analyte (thrombin). During the detection process, a colored reagent labeled DNA aptamer (GNPs-aptamer 1) was placed on the conjugate pad (a glass-fiber membrane) to serve as the detection reagent; another DNA aptamer (aptamer 2) was immobilized on the test zone to serve as the capture reagent. On the control zone, an additional DNA probe (complementary with the detection aptamer 1) could be used to produce a control signal. When a sample solution was applied on the sample application pad, it would migrate up by capillary action and rehydrate the colored reagent labeled DNA aptamer (GNPsaptamer 1) conjugates on the conjugate pad. Then the binding between the colored reagent labeled DNA aptamer (GNPs-aptamer 1) and target analyte (thrombin) occurred. Subsequently, the mixture passed through the test zone and the bounded target analyte was captured by capture reagent (aptamer 2). The response from the test zone is in proportion to the concentration of the target analyte. The schematic illustration is depicted in Fig. 2B . To date, this LFB based technology has reached many fields of research such as medicine, agriculture, food and environmental safety. Recently, several review papers describing LFB [63, 72, 41, 73, 74] , including the paper reported by Posthuma-Trumpie et al. [73] for detection of infectious agents and chemical contaminants and the paper reported by Babacar Ngom et al. [41] for the strengths, weaknesses, opportunities and threats of the LFB. Herein, we aimed to present recent advances of LFBs for biomedical detections, including the investigation of the improvements achieved by signal-amplification strategies, the application of new nanoparticle labels, novel quantitative system and the simultaneous detection.
Signal-amplification strategies
Colored detector reagents in LFBs such as colloidal god nanoparticle (GNPs), latex, europium, chelate-loaded silica, fluorescent immunoliposomes, green microparticle, etc. are used as labels of antibody or aptamer to detect the presence of target analyte. Among the colored particles, GNPs have been extensively employed due to their inherent advantages, such as intense optical properties, vivid color, hybridization and melting properties, fine biocompatibility, excellent chemical tailorability, distance and aggregate size-dependent optical properties. Thus, antibody or aptamer-GNPs have been used to develop LFBs for a wide variety of analytes. Due to low abundance of targets, high sensitivity is highly desired for LFBs. An effective way for improving the sensitivity of the GNPs-based bioassay is to amplify the Au signal by adopting silver enhancement technology to the traditional bioassay [75] [76] [77] [78] [79] [80] [81] . Under the action of the reducing agent, silver ions is prone to gather around the GNPs in the form of silver, the color of the test zone is greatly enhanced due to the silver deposition on the GNPs surface. Wang et al. [78] reported a silver enhancement technologybased sandwich immuno-chromatographic assay for detecting abrin-a. In a typical assay, a range of abrin-a concentrations (0, 0.1, 1.0, 10, 100 and 1000 ng/mL) were measured. The accumulation of the GNPs on the test zone and control zone enabled the visual detection within 10 min. Then, the AgNO 3 pad and reducer pad were orderly covered on the test zone and control zone. Followed by applying 100 μL double distilled water to infiltrate the two pads, the enhancement result of the test strips was determined within 10 min. The detection sensitivity was 0.1 ng/mL and demonstrated to be increased by 100-fold in comparison with the conventional LFB assay. Furthermore, no significant cross-reactivity can be obtained from the test strip, showed excellent detection specificity.
Another alternative approach for enhancing the detection limit is to introduce enzymes as labels into the development of biosensors and bioassays. Horseradish peroxi-dase (HRP), glucose oxidase and alkaline phosphatase are the most commonly used enzymes in the LFBs bioassays [82-84,68,85-87]. Parolo and coworkers [68] presented a HRP-GNPs duallabeled LFB for the sensitive detection of Human IgG (HIgG). This strategy was combining the unique optical properties of GNPs and enzyme catalytic amplification, which produce darker products depositing on the GNP surface to enhance the visual effect and the response intensities. Three different HRP substrates, including 3,3,5,5-Tetramethylbenzidine (TMB), 3-Amino-9-ethylcarbazole (AEC), 3,3-Diaminobenzidinetetrahydrochloride (DAB) were tested on the LFB and the TMB resulted the most suitable for LFB applications. The study comprised two steps as follows: 1) capturing of the HRP-GNPs dual-labeled conjugate on the test zone (insensitive); 2) signal amplification by applying the HRP substrates on the test zone (sensitive). After signal amplification, the LFB gained sensitivity (up to 1 order of magnitude) without losing the simplicity and the detection reproducibility.
Recently, new advances have been made to develop ultrasensitive analyte (DNA) tests by introducing the signal amplification strategyisothermal strand-displacement polymerase reactions (ISDPR) into the LFB bioassay. ISDPR have been developed to overcome the disadvantages of PCR. No thermal cycling is required in the ISDPR, offering distinct advantages with regard to the cost and simplicity of instrumentation. Moreover, ISDPR permits 10 10 -fold amplification of a DNA target sequence within 15 min, and the amplified DNA can be used and detected directly without any further purification [88, 89] . A LFB combined with isothermal strand-displacement technology was proposed by Lie and co-workers for the detection of human genomic DNA in the aqoeous solutions. The ISDPR solution consisted of a biotin modified hairpin DNA probe, a strand displacement primer, target DNA probe, Klenow polymerase exo-, dNTPs and buffer solution [90] . A 41-mer DNA hairpin probe (containing the target DNA binding site; probe 1) is first immobilized on the surface of GNPs. In the present of the target DNA, it would bind on the specific binding site on the hairpin probe, and then open the hairpin probe forming the duplexes on the surface of GNPs. After introducing the primer and the tag (probe 2 and probe 3), the recognition and hybridization with probe 1 occurred. At the same time, probe 1 was undergoing a conformational change and leading to stem separation. In the presence of Klenow polymerase exo-, probe 2 would anneal with the open stem and trigger an extension reaction. During the extension reaction, the target DNA was displaced, which triggered a new round of polymerization reaction. As a result, numerous sequence tagged-duplex DNA complexes were produced throughout this repeating process. In a typical assay, the resulting complexes would be captured on the test zone of the test strip through the binding affinity between the biotin (labeled on the probe 1) and the streptavidin (SA) (immobilized on the test zone). The detection limit of the modified LFS was 0.01 fM of target DNA, which was 1000 times better than published traditional LFS methods. He et al. [91] also reported an ISDPR based LFB for visual detection of R156H-mutant DNA. The detection limit was 1-fM R156H-mutant DNA within 75 min without instrumentation. The specificity was further demonstrated by showing no crossreactivity to distinguish of R156H-and R156C-mutant DNA on the R156 mutation site through the immobilizing of fluorescein-and biotinmodified hairpin probes in the ISDPR process. And the resulting specificity of the assay was 100%.
An interesting attempt was carried out recently by Choi and co-workers [92] upon the applying the traditional sandwich format-based LFB with the 2nd conjugate by immobilizing GNPs with different size on the different antibody, and the antibody was designed to bind specifically with the 1st GNP conjugate. In a typical assay, after the 1st GNPs conjugate was captured on the LFB, the 2nd GNP conjugate would bind on the 1st GNPs to amplify the optical signal by depositing more GNPs on the test zone. In this study, the 1st conjugate was an anti-troponin I antibody immobilized on the 10-nm GNPs blocking with bovine serum albumin (BSA), and the 2nd conjugate was an anti-BSA antibody immobilized on the 40-nm GNPs blocking with human serum albumin. The detection limit of this dual GNP conjugates-based LFB was as low as 0.01 ng / mL troponin I within 10 min, whereas 1 ng / mL was detectable by the conventional LFB method, offering a 100-fold signal amplification method than the conventional LFB.
Applications of new nanoparticle labels
The visible color from the test zone and control zone is generated from the integration and accumulation of the colored detector reagents. Therefore, for successful development of LFB with sufficient sensitivity, the type of colored detector reagents is very important. As mentioned above, the GNPs are the most widely used colored reagent, owing to its notable advantages. However, GNPs still suffer from some drawbacks: the sensitivity is insufficient for low abundance of targets; the signal amplification process could be costly. Therefore, it is significant to finding the suitable and new detector reagents for sensitive detection.
Magnetic nanoparticles and microparticles are attractive as nanomaterials because of their embedded magnetic entities, larger surface-tovolume ratio and they can be magnetically manipulated by using permanent magnets or electromagnets. By considering these advantages, Tang and co-workers [93] synthetised the magnetic nano-gold microspheres (MnGMs; with nano-Fe 2 O 3 particles as core and GNPs as shell) as the colored reagent and employed them for detecting aflatoxin B2 (AFB2) in food samples. The synthesis of the MnGMs comprised six steps: 1) the synthesis of the SDS-Fe 2 O 3 complex; 2) immobilizing chitosan on the surface of Fe 2 O 3 nanoparticles; 3) the synthesis of the chitosan/Fe 2 O 3 nanocomposites; 4) cross-linking glutaraldehyde with chitosan, 5) assembling GNPs on the surface of the formed nanocomposites, 6) obtaining MnGMs by magnetic separation. In this typical competitive immuno-reaction, the test zone and control zone were immobilized with BSA-AFB2 and antimouse IgG, respectively. In the absence of target AFB2 (or lower than the cutoff value), two red lines can be observed from both of the test zone and control zone. In the presence of target AFB2, only one red line can be observed from the control zone. The detection limit of the LFB was as low as 0.9 ng / ml AFB2 without instrument, which was threefold lower compared to a conventional LFB test using gold nanoparticles as colored detector reagents. Moreover, results of the parallel analysis of AFB2 in blank peanut samples and in naturally contaminated samples showed good agreement rate between HPLC method and the LFIBA. Another gold magnetic nanoparticles (GMNs) based LFB was developed for treponema pallidum antibodies (Tp) detection [94] . In this study, a PAA (poly (acrylic acid))-coated GMNs (PGMNs) was prepared with recombinant Treponema pallidum antigens (r-Tp) as the detection reagent. The preparation of detection reagent included the preparation of the pure core/shell of Fe 3 O 4 /GNPs, coating PAA on the surface of GMNs and immobilizing the targeted moieties on the PGMNs. The purpose of coating PAA on the surface of GMNs is that PGMNs are more stable and monodispersed than GMNs. The PGMNs were further investigated and characterized by fourier transform-infrared spectroscopy (FT-IR), transmission electron microscopy, UV−visible scanning spectrophotometry, thermogravimetric analysis, and Zetasizer methodologies. The detection limit of this method was as low as 1 national clinical unit/mL (NCU/mL). The specificity of the PGMNs-based LFIA strips were determined by testing 1020 sera samples from three independent hospitals, exhibiting high values of the specificity for all clinical tests (> 97%).
An immuno-nanoparticle composed of a silver core and a gold shell (Ag/Au) was synthesized by Liao et al. [95] and applied for the fast screening of aflatoxin B 1 (AFB 1 ) in food samples. The synthesis of the core-shell Ag/Au nanocomposites comprised four steps: 1) The synthesis of Ag NPs; 2) the reduction of HAuCl 4 by introducing NaBH 4 solution; 3) the coverage of the Au 0 on the surface of Ag surface. In this study, the Ag/Au nanocomparticle was immobilized with monoclonal anti-AFB 1 primary antibodies, and the resulting conjugates were used as detection reagent in the lateral flow strip test. The detection limit (cutoff value) of the AFB 1 was observed at 0.1 ng / mL within 15 min. High sensitivity was also achieved when a blue dye doped latex beads were used as the colored reagent in the LFB for sensitive DNA detection in aqueous solutions and plasma [96] . The strategy was based on the sandwich format using the target DNA and a pair of DNA probes (capture probe and detection probe). The blue dye doped latex beads was immobilized on the detection probe as the detection reagent, and the capture probe was immobilized on the test zone as the capture reagent. The detection limit was 0.1 nM in aqueous solutions and 3.75 fmol in 50 μL of human plasma.
A carbon nanoparticle based competitive LFB was reported by Sua´rez-Pantaleo´n and coworkers [97] for the detection synthetic phytoregulator forchlorfenuron (CPPU). The detection limit of the carbon nanoparticle based LFB was 89 ng / L, and the results of the parallel analysis of fruit samples with incurred residues showed good agreement rate of two reference methods (ELISA and HPLC).
In addition, the use of fluorescent technique [98] [99] [100] [101] [102] [103] [104] [105] , up-converting phosphorus [106, 107, 59, 74] and technology also allowed an increase in sensitivity and simplicity compared with that for visual detection of traditional colored labels.
New quantitative system
Quantity system is significant for the target analysis, because suitable quantity system can avoid the loss of signal which should also mean a consequent increase of assay sensitivity. Recently, Qin and co-workers [108] introduced the concept of thermal contrast into the LFB based bioassay to improve detection sensitivity. After addition of the targets, the captured GNP-antibody-antigen complex on the test zone enabled the visual detection of the target antigen. At low concentrations of antigen, less GNPs was captured on the test zone, resulting in insufficient bound GNPs for visual detection. A laser or lightemitting diode (LED) and an infrared temperature gun were used to irradiate the GNPs on the test zone and control zone. The thermal contrast can extend the analytical sensitivity of the LFB by 32-fold. They further modification of the assay by combination of higher-absorbing nanoparticles and low-absorbing LFB backing materials. As a result, a 1000-fold improvement in sensitivity was obtained. The use of thermal contrast is a promising novel detection strategy for signal amplification of the LFB bioassay.
Li et al.
[109] also introduced a high power LED (520-540 nm) into the LFB for detection of clenbuterol (CLE) in swine urine. The LED (520-540 nm) was used as light emitter to irradiate the captured GNPs. The reflective optical signal from GNPs was filter and converted to photoelectrical signals. Because GNPs have an affinity for the absorbance in the green region, therefore, the more GNPs were capture on the test strip, the less photoelectrical responses can be obtained. The detection limit of the CLE by the new quantitative system based LFB was 220 pg / mL.
Simultaneous detection
Recently, research in the laboratory was focused on developing new LFBs for simultaneous detection [110] [111] [112] [113] . Compared with the single detection, simultaneous detection offers many advantages such as simple, timesaving, sample saving, and no need for checking the suspected parameters [114, 115, 71] . A combination of colloidal gold nanoparticles and oligonucleotide LFB was described by Yuichi Oku et al. [116] for the simultaneous detection of antigens (HBs antigen) and antibodies (Treponema pallidum, TP) in specimens. The assay was based on sandwich format. Four labeled antigens were used in the study:
GNPs-labeled anti-antigen A, oligonucleotide 1-labeled anti-antigen A, GNPslabeled antigen B and oligonucleotide 1-labeled antigen B were firstly applied on the application pad. After introducing the sample solution (containing antigen A and antibody B) onto the sample application pad, specific bindings including antigen A/anti-antigen A and antibody B/ antigen B occurred. At the same time, two sandwich typed complexes: oligonucleotide 1/antigen A/GNPs and oligonucleotide 1/antibody B/GNPs were formed on the LFB. Subsequently, the solution containing two complexes continued to migrate along the strip. When they reached the two test zone, the two complexes were captured by the complementary oligonucleotide 1 and the complementary oligonucleotide 2 via the DNA-DNA interaction, respectively. Therefore, in the presence of the two target analytes in a specimen, two characteristic red bands can be observed from the two test zones. In contrary, in the absence of target analyte, no red band can be observed. As a result, more than two types of reactions can be detected on a single assay device. The detection limit was 1 / 8 mg / ml for the TP sensing and 5 ng / ml for the HBs sensing.
Zhu et al. [115] detected cardiac troponin I (hs-cTnl) and myoglobin simultaneously to exclude acute myocardial infarction (AMI) via GNPs based LFB. In this study, the specimens of cardiac troponin I (hs-cTnl) and myoglobin were collected from 173 patients with AMI symptoms. The assay was then compared with the commercial LFIA test, and the agreement rates between the two methods were 100%. In the typical assay, two conjugate pads were introduced to the LFB. In the second conjugate pad, monoclonal anti-hs-cTnI detecting antibody (anti-hs-cTnI mAb1) were labeled with GNPs (13 nm), and then coated with biotinylated DNA. Meanwhile, the monoclonal anti-myoglobin detecting antibody (anti-myoglobin mAb1) were also labeled with GNPs (13 nm). Another GNPs with size of 41 nm was coated with streptavidin and then bound with anti-hs-cTnImAb1-labeled GNPs (13 nm) on the second conjugate pad to block the first conjugate pad as an intensifier. After the modified LFB test for the simultaneous detection of cardiac troponin I (hs-cTnl) and myoglobin, two characteristic red bands can be observed from the two test zones. The sensitivity of the modified LFB and the commercial LFB were 100% and 80%, respectively, by studying 20 samples, and the both specificities were 100%. A lateral flow strip for simultaneous detection of cyromazine (CA) and melamine (MA) in foods of animal origin was developed by Le et al. [111] . The assay was based on a competitive binding bioassay using GNPs as label. In a typical LFB assay, anti-CA mAbs and GNPs-coated anti-MA mAbs were firstly added on the conjugate pad. The two test zones and control zone were respectively dispensed with CA-BSA, MA-BSA and goat anti-mouse IgG. In the absence of target analyte, the CG-mAb 2.2.4 / 6A11 or CG-mAb 4.1.4 / 5D8 would be captured by the two test zones which were dispensed with CA-BSA and MA-BSA. In the presence of target analyte (concentration more than 25 ng / ml), no red band can be observed in the corresponding position. A sensitivities limit at 0.22 ng / ml and 0.26 ng / ml were obtained from CA and MA in matrix sample, respectively. The recoveries for CA and MA at three concentration levels (50, 100, and 150 ng / g) were ranged from 73.9% to 104.2%. Using HPLC as confirmatory method, the validation of the ICA test was achieved by analyzing CA and MA in real samples (muscle, liver of swine, cattle and sheep, and milk). The agreement rates between LFBs and HPLC were 100%.
Kolosova et al. [110] developed a multianalyte lateral-flow technique using GNPslabeled monoclonal antibodies for the simultaneous detection of deoxynivalenol (DON) and zearalenone (ZEA). The sensitivities of the tests were estimated to be 1500 μL / kg and 100 μL / kg for DON and ZEA, respectively, and the detection time was less than 10 min. Results from these studies have proved the success of test strip applications.
A combination of GNPs based LFB and logic gates ("OR" and "AND" functions) for proteins and small molecules was described by Chen and co-workers [117] . In this study, thrombin and ATP were used as the inputs, split/integrated aptamers were used as the molecular recognition elements, and the GNPs were used as a tracer. After a complete assay, the output signals could be observed from the color change of the test zone. For the "OR" gate detection, in the absence of any inputs (0,0), no color change can be observed from the test zone; in the presence of either (1,0; 0,1) or both inputs (1,1), color change can be observed from the test zone. For the "AND" gate detection, in the presence of both inputs (1,1), color change can be observed from the test zone; in the absence of any (0,0) or either inputs (1,0; 0,1), no color change can be observed from the test zone. This is the first application of logic gates in LFB detection, opening the new possibility for the analyte analysis in bioassays.
Conclusions and outlook
This review has summarized the recent progress on LFBs. Major advantages found on LFBs are portable, inexpensive, simple, robust, short assay time (generally several minutes), and do not require complicated equipment and skilled technicians. The unique and remarkable properties of LFBs have paved the way and opened the possibility for the detecting disease biomarkers, infectious agents and biothreat agents in medicine, agriculture, food and environmental safety. The studies described above demonstrate the recent progress of LFB in improving sensitivity including the signalamplification strategies and new nanoparticle labels for achieving lower detection limits. In addition, the LFBs are promising in simultaneous detection of several analytes in contaminated or hazardous samples effectively outside the laboratory. Furthermore, recent breakthroughs in research in the LFB bioassays could also encourage more innovation in the design of novel quantitative system, which would overcome the loss of signal and extend the analytical sensitivity. However, the challenges for current research are 1) "How will the LFB technologies work without complicated sample pretreatment?" and 2) "Will it be possible to achieve low volume detection in LFB analysis?" Therefore, future innovative research is expected to lead to advanced LFB by simplicity and practicability improvement, including sample pad pretreatment strategy and introducing with other major technological advances, such as microfluidic technology. 
